Latest Market Access News

American West Metals has begun trading on the OTCQB Venture Exchange, boosting its visibility among US investors and signaling potential future listings on major US exchanges amid rising demand for domestic critical minerals.

Caravel Minerals has signed a non-binding MOU with Adani’s Kutch Copper to jointly advance the Caravel Copper Project toward a 2026 Final Investment Decision, exploring funding and offtake agreements.

Group 6 Metals has materially improved its debt position by converting warrants under its April 2025 recapitalisation plan, signaling renewed shareholder confidence and operational momentum.

Austral Resources Australia Ltd has successfully completed a $40 million capital raise and is reinstated to ASX trading, positioning itself as a mid-tier copper producer with a dual-hub operation in Queensland.

Artrya secures participation from Mass General Brigham, a leading U.S. cardiovascular research center, in its pivotal SAPPHIRE Study launching in early 2026. This collaboration aims to validate Artrya’s AI-powered Salix platform for earlier and more effective coronary artery disease detection.

NuEnergy Gas Limited has announced a $4.62 million entitlement offer, primarily to fund early gas sales and development of its Indonesian coal bed methane assets. The offer is partially underwritten by a major shareholder and supports key milestones in the company’s transition to commercial production.

Anteris Technologies has secured FDA approval to commence its pivotal PARADIGM clinical trial, testing its innovative DurAVR Transcatheter Heart Valve against established devices in patients with severe aortic stenosis.

Cleo Diagnostics has secured positive FDA feedback and nearly 1,600 biobank samples, accelerating its ovarian cancer blood test development ahead of a planned 2026 U.S. market entry.

HeraMED has bolstered its cash position with a $1.98 million capital raise and is on the cusp of finalizing two pivotal U.S. commercial agreements, signaling a major step forward for its digital maternity care platform.

Caravel Minerals has made significant strides in advancing its Caravel Copper Project, initiating its Definitive Feasibility Study and securing critical funding amid a tightening copper market.

Po Valley Energy reported consistent gas production and strong cash flow in Q3 2025, while advancing development plans and a new gas sales agreement in Italy.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.